Recalls / Active ingredient / Sirolimus
Sirolimus
5 FDA drug recalls involving the active ingredient “Sirolimus”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2024-05-01 | Class III | Sirolimus Tablets 1mg Tablets 100-count bottle, Rx Only, Distributed by: Dr. Reddy's Laboratories Inc., Prince | Dr. Reddy's Laboratories, Inc. |
| 2022-10-13 | Class III | Fyarro (sirolimus protein-bound particles for injectable suspension (albumin-bound), 100 mg per vial, NDC 8080 | Aadi Bioscience |
| 2022-05-03 | Class III | Sirolimus Oral Solution, 1 mg/mL, 60 mL bottle, Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario Canada | Apotex Corp. |
| 2021-05-12 | Class III | Sirolimus Tablets 1 mg, 30 Tablets (5 blister cards x 6 unit doses), Rx only, Packaged and Distributed by: Ame | American Health Packaging |
| 2016-06-03 | Class III | Sirolimus Tablets, 1 mg, 100-count bottle, Rx only, Manufactured by: Dr. Reddy's Laboratories Limited, Visakha | Dr. Reddy's Laboratories, Inc. |